[Federal Register Volume 65, Number 130 (Thursday, July 6, 2000)]
[Notices]
[Page 41727]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-17080]


=======================================================================
-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 731-TA-828 (Final)]


Bulk Acetylsalicylic Acid (Aspirin) From China

Determination

    On the basis of the record \1\ developed in the subject 
investigation, the United States International Trade Commission 
determines, pursuant to section 735(b) of the Tariff Act of 1930 (19 
U.S.C. 1673d(b)) (the Act), that an industry in the United States is 
threatened with material injury by reason of imports from China of bulk 
acetylsalicylic acid (aspirin), provided for in subheadings 2918.22.10 
and 3003.90.00 of the Harmonized Tariff Schedule of the United States, 
that have been found by the Department of Commerce to be sold in the 
United States at less than fair value (LTFV). The Commission further 
determines that it would not have found material injury but for the 
suspension of liquidation.
---------------------------------------------------------------------------

    \1\ The record is defined in sec. 207.2(f) of the Commission's 
Rules of Practice and Procedure (19 CFR Sec. 207.2(f)).
---------------------------------------------------------------------------

Background

    The Commission instituted this investigation effective May 28, 
1999, following receipt of a petition filed with the Commission and the 
Department of Commerce by Rhodia, Inc., Cranbury, NJ. The final phase 
of the investigation was scheduled by the Commission following 
notification of a preliminary determination by the Department of 
Commerce that imports of bulk aspirin from China were being sold at 
LTFV within the meaning of section 733(b) of the Act (19 U.S.C. 
1673b(b)). Notice of the scheduling of the Commission's investigation 
and of a public hearing to be held in connection therewith was given by 
posting copies of the notice in the Office of the Secretary, U.S. 
International Trade Commission, Washington, DC, and by publishing the 
notice in the Federal Register of February 4, 2000 (65 FR 5659). The 
hearing was held in Washington, DC, on May 18, 2000, and all persons 
who requested the opportunity were permitted to appear in person or by 
counsel.
    The Commission transmitted its determination in this investigation 
to the Secretary of Commerce on June 30, 2000. The views of the 
Commission are contained in USITC Publication 3314 (June 2000), 
entitled Bulk Acetylsalicylic Acid (Aspirin) from China: Investigation 
No. 731-TA-828 (Final).

    By order of the Commission.

    Issued: June 29, 2000.
Donna R. Koehnke,
Secretary.
[FR Doc. 00-17080 Filed 7-5-00; 8:45 am]
BILLING CODE 7020-02-P